Dare Bioscience, Inc. State and Local Income Tax Expense (Benefit), Continuing Operations
Dare Bioscience, Inc. (DARE) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $0 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2014-11-13
- Dare Bioscience, Inc. state and local income tax expense (benefit), continuing operations for the quarter ending 2014-09-30 was $0.00.
- Dare Bioscience, Inc. state and local income tax expense (benefit), continuing operations for the quarter ending 2014-06-30 was $0.00.
- Dare Bioscience, Inc. state and local income tax expense (benefit), continuing operations for the quarter ending 2014-03-31 was $0.00.
- Dare Bioscience, Inc. state and local income tax expense (benefit), continuing operations for the quarter ending 2013-09-30 was $0.00.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 3 month | State and Local Income Tax Expense (Benefit), Continuing Operations 6 month | State and Local Income Tax Expense (Benefit), Continuing Operations 9 month |
|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-27 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |